{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:15Z","timestamp":1792215795192,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24141901200"],"award-info":[{"award-number":["24141901200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117535","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:58Z","timestamp":1792081738000},"page":"117535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PLA2G2A inhibition by Aristolochic acid IVa suppresses colonic inflammation in experimental colitis"],"prefix":"10.1016","volume":"190","author":[{"given":"Wei-ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-wen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-juan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yue","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-shi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117535_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cgh.2024.04.042","article-title":"The IBD clinic of tomorrow: holistic, patient-centric, and value-based care","volume":"23","author":"Click","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117535_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2012.07.009","article-title":"The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity","volume":"18","author":"Alhouayek","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.117535_bb0015","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ibd\/izaf121","article-title":"Prostaglandins and inflammatory bowel disease: from mechanism to clinic","volume":"31","author":"Huang","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.117535_bb0020","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2026.117535_bb0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1515\/CCLM.1998.133","article-title":"Elevated group 11 phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease","volume":"36","author":"Haapam\u00e4ki","year":"1998","journal-title":"CCLM"},{"issue":"12","key":"10.1016\/j.intimp.2026.117535_bb0030","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1136\/gutjnl-2016-312609","article-title":"Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis","volume":"66","author":"Dotti","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jep.2009.05.028","article-title":"Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources","volume":"125","author":"Heinrich","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117535_bb0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1039\/c3np70114j","article-title":"Naturally occurring aristolochic acid analogues and their toxicities","volume":"31","author":"Michl","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.117535_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0278-6915(92)90031-F","article-title":"Epidemiology of Balkan endemic nephropathy","volume":"30","author":"Ceovi\u0107","year":"1992","journal-title":"Food Chem. Toxicol."},{"issue":"8842","key":"10.1016\/j.intimp.2026.117535_bb0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2026.117535_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0165-1218(88)90052-3","article-title":"Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives","volume":"206","author":"Pezzuto","year":"1988","journal-title":"Mutat. Res."},{"issue":"Pt A","key":"10.1016\/j.intimp.2026.117535_bb0060","first-page":"1","article-title":"Pharmaceuticals. Volume 100 A. A review of human carcinogens","volume":"100","author":"Humans IWGotEoCRt","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"issue":"8","key":"10.1016\/j.intimp.2026.117535_bb0065","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00204-021-03077-1","article-title":"Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo","volume":"95","author":"Wan","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2026.117535_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112081","article-title":"Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism","volume":"142","author":"Xian","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2026.117535_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice","volume":"56","author":"Sato","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117535_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.761593","article-title":"Quantitative determination and toxicity evaluation of Aristolochic acid analogues in Asarum heterotropoides F. Schmidt (Xixin) and traditional Chinese patent medicines","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117535_bb0085","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1021\/acs.jafc.4c00751","article-title":"Comprehensive HRMS screening and risk assessments of Aristolochic acid analogues in Asari Radix et Rhizoma and related commercial health products","volume":"72","author":"Hu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2026.117535_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156557","article-title":"Aristolochic acid IVa ameliorates arthritis in SKG mice by regulating macrophage polarization and Th17\/Treg balance","volume":"139","author":"Gao","year":"2025","journal-title":"Phytomedicine"},{"issue":"36","key":"10.1016\/j.intimp.2026.117535_bb0095","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1021\/bi0258593","article-title":"Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure","volume":"41","author":"Chandra","year":"2002","journal-title":"Biochemistry"},{"issue":"7873","key":"10.1016\/j.intimp.2026.117535_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.intimp.2026.117535_bb0105","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.117535_bb0110","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.intimp.2026.117535_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.intimp.2026.117535_bb0120","doi-asserted-by":"crossref","first-page":"D1238","DOI":"10.1093\/nar\/gkab1011","article-title":"HIT 2.0: an enhanced platform for herbal ingredients' targets","volume":"50","author":"Yan","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117535_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/9780470559277.ch110180","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"3","author":"Lomenick","year":"2011","journal-title":"Curr Protoc Chem Biol"},{"issue":"9","key":"10.1016\/j.intimp.2026.117535_bb0130","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.intimp.2026.117535_bb0135","first-page":"4557","article-title":"A guide to histomorphological evaluation of intestinal inflammation in mouse models","volume":"7","author":"Erben","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0140","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00204-021-03059-3","article-title":"Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells","volume":"95","author":"Bellamri","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117535_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101457","article-title":"Updating phospholipase A(2) biology","volume":"10","author":"Murakami","year":"2020","journal-title":"Biomolecules"},{"issue":"18","key":"10.1016\/j.intimp.2026.117535_bb0150","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types, regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2026.117535_bb0155","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.2337\/db11-1179","article-title":"An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats","volume":"61","author":"Iyer","year":"2012","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.intimp.2026.117535_bb0160","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.7150\/ijbs.131531","article-title":"Macrophage-orchestrated metabolic sensing drives IBD pathogenesis: a framework for targeted therapy","volume":"22","author":"Guan","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117535_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11418-022-01665-8","article-title":"Non-carcinogenic\/non-nephrotoxic aristolochic acid IVa exhibited anti-inflammatory activities in mice","volume":"77","author":"Liu","year":"2023","journal-title":"J. Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00914317","article-title":"Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid","volume":"12","author":"Vishwanath","year":"1988","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2026.117535_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00914195","article-title":"Selective inhibition OF group-II phospholipases-A2 BY quercetin","volume":"17","author":"Lindahl","year":"1993","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(89)90299-3","article-title":"Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils","volume":"1001","author":"Rosenthal","year":"1989","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0162-3109(93)90061-T","article-title":"Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation","volume":"26","author":"Moreno","year":"1993","journal-title":"Immunopharmacology"},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0190","first-page":"300","article-title":"Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2","volume":"8","author":"Glaser","year":"1995","journal-title":"Skin Pharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117535_bb0195","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.7150\/thno.86623","article-title":"Functional mass spectrometry imaging maps phospholipase-A2 enzyme activity during osteoarthritis progression","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.intimp.2026.117535_bb0200","first-page":"211","article-title":"Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme","volume":"12","author":"Pruzanski","year":"1985","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0205","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(85)90640-X","article-title":"Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid","volume":"36","author":"Vadas","year":"1985","journal-title":"Life Sci."},{"issue":"5034","key":"10.1016\/j.intimp.2026.117535_bb0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1948070","article-title":"Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate","volume":"254","author":"Scott","year":"1991","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbalip.2018.08.017","article-title":"Roles of secreted phospholipase A2 group IIA in inflammation and host defense","volume":"1864","author":"Dore","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tibs.2009.08.003","article-title":"Catalytic and non-catalytic functions of human IIA phospholipase A2","volume":"35","author":"Birts","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.117535_bb0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/emmm.201000072","article-title":"A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis","volume":"2","author":"Boilard","year":"2010","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.117535_bb0230","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.chembiol.2020.06.011","article-title":"Pharmacological targeting of vacuolar H(+)-ATPase via subunit V1G combats multidrug-resistant cancer","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117535_bb0235","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1016\/j.apsb.2026.03.054","article-title":"Engineered extracellular vesicles for combinatorial cancer therapy and imaging","volume":"16","author":"La'ah","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.intimp.2026.117535_bb0240","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ymthe.2025.01.025","article-title":"Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia","volume":"33","author":"Zhang","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0245","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1038\/s41467-024-50283-3","article-title":"Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117535_bb0250","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2026.117535_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105767","article-title":"Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism","volume":"171","author":"Dong","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0260","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12951-024-02724-w","article-title":"Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy","volume":"22","author":"Tang","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.intimp.2026.117535_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161625","article-title":"Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium","volume":"14","author":"Ren","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117535_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121567","article-title":"5-Aminosalicylic acid distribution into the intestinal membrane along the gastrointestinal tract after Oral Administration in Rats","volume":"16","author":"Maeda","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.intimp.2026.117535_bb0275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pharma2010003","article-title":"Signal detection study focusing on differences in the drug delivery system of oral 5-aminosalicylate for inflammatory bowel disease using the Japanese pharmacovigilance database","volume":"2","author":"Noguchi","year":"2023","journal-title":"Pharmacoepidemiology"},{"issue":"3","key":"10.1016\/j.intimp.2026.117535_bb0280","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","article-title":"Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease","volume":"29","author":"Mehta","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117535_bb0285","series-title":"The Pharmacopoeia of the Peoples Republic of China 2025 Edition","author":"Committee TP","year":"2025"},{"issue":"07","key":"10.1016\/j.intimp.2026.117535_bb0290","first-page":"1295","article-title":"Distribution and content of 3 aristolochic acids and 2 aristololactams in different parts of Asarum heterotropoides var. mandshuricum, A. sieboldii and A. sieboldii var. seoulense","volume":"21","author":"Zhang","year":"2019","journal-title":"World Sci. Technol. Modern. Tradit. Chin. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:16:13Z","timestamp":1792214173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S1567576926013834"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117535","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLA2G2A inhibition by Aristolochic acid IVa suppresses colonic inflammation in experimental colitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117535"}}